{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-065718","form_type":"8-K","ticker":"SXTP","cik":"0001946563","company_name":"60 DEGREES PHARMACEUTICALS, INC.","filed_at":"2025-07-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.668880+00:00","generated_at":"2026-05-18T05:50:45.890550+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"60 Deg Pharma closes $5M public offering, up to $10M with warrant exercise","bullets":["Gross proceeds $5M from sale of 2,631,578 units (share/pre-funded warrant + warrants) at $1.90/unit.","Short-term Series A-2 warrants (18-mo term) could add $5M if fully cash-exercised; no guarantee.","Net proceeds earmarked for working capital and general corporate purposes.","H.C. Wainwright acted as exclusive placement agent; offering closed July 16, 2025.","Offering made under effective S-1 filed July 7, 2025 (SEC File No. 333-288550)."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-065718","json":"https://secwatch.observer/filing/0001213900-25-065718.json","markdown":"https://secwatch.observer/filing/0001213900-25-065718.md","text":"https://secwatch.observer/filing/0001213900-25-065718.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1946563/000121390025065718/0001213900-25-065718-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1946563/000121390025065718/ea0249438-8k_60degrees.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T05:50:45.890550+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}